RGX-121

· REGENXBIO Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RGX-121, covering 2025-01-28 to 2025-01-28. Get the full timeline:

Most recent: Clinical Trial Update: RGX-121 Gene Therapy in Children 5 Years of Age and Over With MPS II (Hunter Syndrome) [Phase 1, Phase 2]